|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.150 GBX | 0.00% |
|
-3.08% | -55.63% |
| 29/05 | Poolbeg Pharma PLC - Shareholder/Analyst Call | |
| 27/05 | Poolbeg Pharma shares up after US FDA orphan drug designation | AN |
EPS & Dividend: Poolbeg Pharma PLC
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0074 | -0.0094 | -0.0079 | -0.0116 | -0.0099 | -0.0083 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 0.0950 | 0.0605 | 0.0905 | 0.0710 | 0.0315 | 0.0315 |
| Nbr of stocks (in thousands) | 5,00,000 | 5,00,000 | 5,00,000 | 5,00,000 | 6,97,200 | - |
| Announcement Date | 02/03/22 | 30/03/23 | 30/04/24 | 20/05/25 | - | - |
1GBP in Million2GBP
Estimates
Upcoming events: Poolbeg Pharma PLC
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| - | - | -3.18x | 2.63x | - | ||
| -.--% | -.--% | 47.59x | 5.19x | 8.06x | ||
| 1.7% | 1.94% | 17.08x | 2.99x | 4.19x | ||
| -.--% | -.--% | -23.67x | 1.28x | 5.91x | ||
| -.--% | -.--% | -57.55x | - | - | ||
| -.--% | -.--% | -18.06x | 53.6x | 40.28x | ||
| -.--% | -.--% | 24.56x | 2.04x | 4.3x | ||
| -.--% | -.--% | 13.28x | 2.08x | 2.61x | ||
| -.--% | -.--% | 1970.31x | 13.05x | 25.43x | ||
| -.--% | -.--% | 19.13x | 4.31x | 4.6x | ||
| Average | 0.19% | 0.22% | 198.95x | 9.68x | 11.92x | |
| Weighted average by Cap. | 0.27% | 0.31% | 144.36x | 9.76x | 11.08x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition